SearchDictionaryMobileLogin

Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder.

AbstractAIMS: To investigate dexamphetamine transfer into milk, infant doses and effects in the breast-fed infant. METHODS: Four women taking dexamphetamine, and their infants were studied. RESULTS: The median maternal dexamphetamine dose was 18 mg day(-1) (range 15-45 mg day(-1)). Median (interquartile range) descriptors were 3.3 (2.2-4.8) for milk/plasma ratio, 21 microg kg(-1) day(-1) (11-39) for absolute infant dose and 5.7% (4-10.6%) for relative infant dose. No adverse effects were seen. In three infants tested, dexamphetamine in plasma was undetected in one (limit of detection 1 microg l(-1)) and present at 18 microg l(-1) and 2 microg l(-1) in the other two. CONCLUSION: Dexamphetamine readily transfers into milk. The relative infant dose was <10% and within a range that is generally accepted as being 'safe' in the short term.
AuthorsKenneth F Ilett, L Peter Hackett, Judith H Kristensen, Rolland Kohan (Affiliation: Pharmacology Unit M510, School of Medicine and Pharmacology, University of Western Australia, 35 Stirling Hwy, Crawley, 6009 Australia. ken.ilett at uwa.edu.au)
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 63 Issue 3 Pg. 371-5 (Mar 2007) ISSN: 0306-5251 England
PMID17380592 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dextroamphetamine
Topics
  • Adult
  • Attention Deficit Disorder with Hyperactivity (drug therapy)
  • Breast Feeding
  • Dextroamphetamine (adverse effects)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Milk, Human (chemistry)
  • Pregnancy